降血压药物,降低和降低血压
Jing Song1, Liangkai Chen2,3, Hui Xiong4
1Centre for Public Health and Policy, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom (J.S., S.P.-R., G.A.M., F.J.H.).
Hypertension (Dallas, Tex. : 1979)
|September 5, 2024
概括
减少摄入量可显著降低治疗高血压患者的血压. 减少的有效性取决于所使用的降血压药物的类别.
科学领域:
- 心血管医学 心血管医学
- 临床药理学 临床药理学
- 营养科学 营养科学
背景情况:
- 高血压管理涉及药物治疗和生活方式改变,如减少.
- 在各种抗高血压药物类别中减少的差异性影响仍然不完全理解.
研究的目的:
- 在接受药物治疗的高血压患者中,研究减少摄入量和血压控制之间的剂量反应关系.
- 评估不同类型的降血压药物如何影响血压对降的反应.
主要方法:
- 进行了系统的文献搜索,直到2024年7月9日,确定了随机对照试验.
- 使用仪表变量和随机效应模型进行的元分析评估了减少的剂量-反应效应 (通过24小时尿液分泌量来衡量) 对血压的影响.
- 亚组分析探讨了基于抗高血压药物类别,年龄,基线/血压和研究持续时间的变化.
主要成果:
- 包括35项涉及2885名参与者的研究,研究持续时间中位数为28天.
- 尿液24小时内分泌量减少100毫摩尔与静脉血压 (6.81毫米升),静脉血压 (3.85毫米升) 和平均动脉压 (4.83毫米升) 的显著下降相关.
- 降低的降血压效应在β阻塞剂,氨酸-氨酸-阿尔多斯特系统抑制剂和双重治疗中更为明显,但在其他亚组中没有显著差异.
结论:
- 在接受治疗的高血压患者中,减少摄入量和降低血压之间存在明显的剂量反应关联.
- 从限制中降低血压的幅度是由使用的特定类抗高血压药物调节的.
相关概念视频
01:16Antihypertensive Drugs: Action of Diuretics
634
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
634
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
510
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
510
01:25Antihypertensive Drugs: Direct Renin Inhibitors
511
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
511
01:28Factors affecting Blood pressure
3.0K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
3.0K
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
476
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
476
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
614
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
614